Takeda Pharmaceutical Company Limited Shares Sold by Sippican Capital Advisors - MarketBeat
| TKD Stock | EUR 25.01 0.12 0.48% |
Roughly 54% of Takeda Pharmaceutical's investor base is interested to short. The analysis of current outlook of investing in Takeda Pharmaceutical suggests that many traders are impartial regarding Takeda Pharmaceutical's prospects. The current market sentiment, together with Takeda Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Takeda Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Takeda Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Takeda daily returns and investor perception about the current price of Takeda Pharmaceutical as well as its diversification or hedging effects on your existing portfolios.
Takeda |
Takeda Pharmaceutical Company Limited Shares Sold by Sippican Capital Advisors MarketBeat
Read at news.google.com
 |
Takeda Pharmaceutical Fundamental Analysis
We analyze Takeda Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Takeda Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Takeda Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Takeda Pharmaceutical is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Takeda Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Takeda Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Takeda Pharmaceutical could also be used in its relative valuation, which is a method of valuing Takeda Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Takeda Pharmaceutical Related Equities
| 3GH | KAUFMAN ET | 3.25 | ||||
| 47U | QUEEN S | 2.17 | ||||
| ROW | Texas Roadhouse | 1.78 | ||||
| E6Q | Gold Road | 0.83 | ||||
| ZFI1 | ZURICH INSURANCE | 0.70 | ||||
| QBE | QBE Insurance | 0.87 | ||||
| 2OX | Goosehead Insurance | 4.56 |
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |